Bruker (BKD) Stock Forecast & Price Target
BKD Analyst Ratings
Moderate Buy
5Buy4Hold1Sell
Based on 10 analysts giving stock ratings to Bruker in the past 3 months
BKD Stock 12 Month Forecast
Average Price Target
EUR 54.76▲(7.63% Upside)Based on 10 Wall Street analysts offering 12 month price targets for Bruker in the last 3 months. The average price target is EUR 54.76 with a high forecast of EUR 71.43 and a low forecast of EUR 44.64. The average price target represents a 7.63% change from the last price of EUR 50.88.
Past 12 Months12 Month ForecastDec2025Sep2026
HighEUR 71.43
AverageEUR 54.76
LowEUR 44.64
Highest Price TargetHighestEUR 71.43Average Price TargetEUR 54.76Lowest Price TargetLowestEUR 44.64
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Casey Woodring | J.P. Morgan | EUR 53.57 | hold | 5.29%Upside | Downgraded | 10/14/26 | ||
| Daniel Brennan | TD Cowen | EUR 53.57→EUR 55.36 | hold | 8.80%Upside | Reiterated | 10/13/26 | ||
| Luke Sergott | Barclays | EUR 51.79→EUR 62.50 | buy | 22.84%Upside | Reiterated | 10/07/26 | ||
| Evie Koslosky | Goldman Sachs | EUR 35.71→EUR 44.64 | sell | -12.26%Downside | Reiterated | 10/05/26 | ||
| Subbu Nambi | Guggenheim | EUR 62.50→EUR 64.29 | buy | 26.35%Upside | Reiterated | 10/01/26 | ||
| Puneet Souda | Leerink Partners | EUR 53.57→EUR 71.43 | buy | 40.39%Upside | Reiterated | 09/29/26 | ||
| Patrick B Donnelly | Citi | EUR 53.57→EUR 47.32 | hold | -6.99%Downside | Reiterated | 08/05/26 | ||
| Daniel Arias | Stifel Nicolaus | EUR 40.18→EUR 44.64 | hold | -12.26%Downside | Reiterated | 08/05/26 | ||
| Evan Stampler | Wells Fargo | EUR 49.11 | buy | -3.49%Downside | Reiterated | 08/05/26 | ||
| Michael Ryskin | Bank of America Securities | ― | buy | ― | Reiterated | 08/05/26 | ||
| Michael Polark | Wolfe Research | ― | hold | ― | Downgraded | 06/01/26 | ||
| Dan Leonard | RBC Capital | EUR 35.71→EUR 40.18 | hold | -21.03%Downside | Assigned | 05/07/26 | ||
| Tycho Peterson | Jefferies | EUR 49.11→EUR 44.64 | buy | -12.26%Downside | Reiterated | 02/12/26 | ||
| Doug Schenkel | UBS | EUR 53.57 | buy | 5.29%Upside | Upgraded | 12/10/25 | ||
| Natalya Davies | Rothschild & Co Redburn | EUR 53.57 | buy | 5.29%Upside | Reiterated | 11/20/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Casey Woodring | 10/14/26 | EUR 53.57 | hold | 5.29%Upside | Downgraded | J.P. Morgan | ||
| Daniel Brennan | 10/13/26 | EUR 53.57→EUR 55.36 | hold | 8.80%Upside | Reiterated | TD Cowen | ||
| Luke Sergott | 10/07/26 | EUR 51.79→EUR 62.50 | buy | 22.84%Upside | Reiterated | Barclays | ||
| Evie Koslosky | 10/05/26 | EUR 35.71→EUR 44.64 | sell | -12.26%Downside | Reiterated | Goldman Sachs | ||
| Subbu Nambi | 10/01/26 | EUR 62.50→EUR 64.29 | buy | 26.35%Upside | Reiterated | Guggenheim | ||
| Puneet Souda | 09/29/26 | EUR 53.57→EUR 71.43 | buy | 40.39%Upside | Reiterated | Leerink Partners | ||
| Patrick B Donnelly | 08/05/26 | EUR 53.57→EUR 47.32 | hold | -6.99%Downside | Reiterated | Citi | ||
| Daniel Arias | 08/05/26 | EUR 40.18→EUR 44.64 | hold | -12.26%Downside | Reiterated | Stifel Nicolaus | ||
| Evan Stampler | 08/05/26 | EUR 49.11 | buy | -3.49%Downside | Reiterated | Wells Fargo | ||
| Michael Ryskin | 08/05/26 | ― | buy | ― | Reiterated | Bank of America Securities | ||
| Michael Polark | 06/01/26 | ― | hold | ― | Downgraded | Wolfe Research | ||
| Dan Leonard | 05/07/26 | EUR 35.71→EUR 40.18 | hold | -21.03%Downside | Assigned | RBC Capital | ||
| Tycho Peterson | 02/12/26 | EUR 49.11→EUR 44.64 | buy | -12.26%Downside | Reiterated | Jefferies | ||
| Doug Schenkel | 12/10/25 | EUR 53.57 | buy | 5.29%Upside | Upgraded | UBS | ||
| Natalya Davies | 11/20/25 | EUR 53.57 | buy | 5.29%Upside | Reiterated | Rothschild & Co Redburn |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Bruker
3 Months
Success Rate10/17 ratings generated profit
59%
Average Return
+3.19%
Copying Luke Sergott's trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of +3.19% per trade.
1 Year
Success Rate13/17 ratings generated profit
76%
Average Return
+24.05%
Copying Luke Sergott's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +24.05% per trade.
2 Years
Success Rate16/17 ratings generated profit
94%
Average Return
+39.42%
Copying Luke Sergott's trades and holding each position for 2 Years would result in 94.12% of your transactions generating a profit, with an average return of +39.42% per trade.
BKD Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 7 | 6 | 10 | 7 | 9 |
| Hold | 6 | 7 | 6 | 6 | 6 |
| Sell | 0 | 2 | 2 | 3 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 13 | 15 | 18 | 16 | 17 |
In the current month, BKD has received 9 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. BKD average Analyst price target in the past 3 months is 54.76.
BKD Financial Forecast
HighEUR 0.40
ConsensusEUR 0.38
LowEUR 0.35
BKD Earnings Forecast
Next quarter’s earnings estimate for BKD is EUR 0.38 with a range of EUR 0.35 to EUR 0.40. The previous quarter’s EPS was EUR 0.44. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 780M
ConsensusEUR 775M
LowEUR 760M
BKD Sales Forecast
Next quarter’s sales forecast for BKD is EUR 774.66M with a range of EUR 760.37M to EUR 779.53M. The previous quarter’s sales results were EUR 750.79M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
BKD Stock Forecast FAQ
What is DE:BKD’s average 12-month price target, according to analysts?
Based on analyst ratings, Bruker’s 12-month average price target is €54.76.
What is DE:BKD’s upside potential, based on the analysts’ average price target?
Bruker has 7.63% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Bruker a Buy, Sell or Hold?
Bruker has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 4 hold ratings and 1 sell ratings.
What is Bruker’s share price target?
The average share price target for Bruker is €54.76. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €71.43, and the lowest forecast is €44.64. The average share price target represents a 7.63% increase from the current price of €50.88.
What do analysts say about Bruker?
Bruker’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Bruker?
To buy shares of DE:BKD, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
